Study finds remdesivir, hydroxychloroquine have 'little' impact on mortality in COVID-19 patients
A clinical trial conducted by the World Health Organization found that Gilead Sciences Inc.'s remdesivir, hydroxychloroquine, AbbVie's...
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Clinical Trials | COVID-19 | Health | Hydroxychloroquine | International Medicine & Public Health | Study | WHO